Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole injection PK and safety in high-risk invasive fungal infection patients
CTR20170811Phase 3Completed
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of posaconazole in invasive mycoses, sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Jul 2017; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on CTR20170811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170811.